Pulmonary Disease in the Immunocompromised Host, An Issue of Clinics in Chest Medicine
Series: The Clinics: Internal Medicine;
- Publisher's listprice EUR 104.99
-
44 536 Ft (42 415 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 13% (cc. 5 790 Ft off)
- Discounted price 38 746 Ft (36 901 Ft + 5% VAT)
44 536 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier
- Date of Publication 4 February 2025
- ISBN 9780443246487
- Binding Hardback
- No. of pages pages
- Size 254x177 mm
- Weight 450 g
- Language English 685
Categories
Long description:
In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.
- Contains 16 relevant, practice-oriented topics including COVID-19 and emerging lung infections in the immunocompromised patient; pulmonary immunocompromise in stem cell transplantation and cellular therapy; pulmonary immunocompromise in solid organ transplantation; pulmonary immunocompromise in chronic and high dose steroid therapy; and more
- Provides in-depth clinical reviews on pulmonary disease in the immunocompromised host, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Table of Contents:
Algorithmic Approach to an Abnormal Computed Tomography of the Chest in the Immunocompromised Host
Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia
Host-Directed Adjunctive Therapies in Immunocompromised Patients with Pneumonia
Sequelae of Immunocompromised Host Pneumonia
Evaluation of Inborn Errors of Immunity Among Patients with Opportunistic Pulmonary Infection
The Microbiome and Pulmonary Immune Function
Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia
Acute Lung Injury in Immunocompromised Patients
Pulmonary Complications in Hematologic Malignancies
Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy
Pulmonary Immunocompromise in Solid Organ Transplantation
Pulmonary Immunocompromise in Chronic and High-dose Steroid Therapy
Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases
Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease
Coronavirus Disease 2019 and Emerging Lung Infections in the Immunocompromised Patient
